Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Taku Asano(Amsterdam UMC Location University of Amsterdam), Patrick W. Serruys(Erasmus MC), Jan J. Piek(Amsterdam University Medical Centers), Mathias Vrolix(Ziekenhuis Oost-Limburg), Manel Sabaté(Hospital Clínico San Carlos), Joanna J. Wykrzykowska(University Medical Center Groningen), Pedro Canas da Silva, Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Johan H. C. Reiber(Erasmus University Rotterdam), Adel Aminian(Grand Charleroi Hospital), Yosuke Miyazaki(Yamaguchi University), Andrés Íñiguez(University Hospital Complex Of Vigo), Giovanni Amoroso(OLVG), Yohei Sotomi(Kyoto University), Erhan Tenekecioğlu(Erasmus University Rotterdam), Pim van de Harst(University Medical Center Groningen), Clemens von Birgelen(University of Twente), Rosana Hernández‐Antolín(Hospital Universitario Ramón y Cajal), Salvatore Brugaletta(Hospital Clínic de Barcelona), Pieter C. Smits(Cardiovascular European Research Center), Vasco Gama Ribeiro(Instituto Superior de Espinho), Luc Janssens(Imelda Hospital), Hélder Pereira(University of Lisbon), Yuki Katagiri(University of Amsterdam), Carlos Collet(Onze Lieve Vrouwziekenhuis Hospital)
Cited by 27
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k